Cost-effectiveness of ticagrelor versus clopidogrel in patients with acute coronary syndromes in Canada

BACKGROUND: Ticagrelor demonstrated a significant reduction in major cardiac events in patients with acute coronary syndrome (ACS) compared with clopidogrel in the Platelet Inhibition and Patient Outcomes (PLATO) trial. The objective of this study was to assess the cost-effectiveness of ticagrelor c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Grima, Daniel T, Brown, Stephen T, Kamboj, Laveena, Bainey, Kevin R, Goeree, Ron, Oh, Paul, Ramanathan, Krishnan, Goodman, Shaun G
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2014
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3908913/
https://ncbi.nlm.nih.gov/pubmed/24493930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S51052
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge